Epstein Secrets

From: To: Jeffrey Epstein Subject: Jeff Port Date: Thu, 02 Jul 2015 19:38:50 +0000 Jeff is tentatively scheduled for 3pm on July 9th...I told him we will circle back next we

2 Jul 2015 19:38:50 +0000 Jeff is tentatively scheduled for 3pm on July 9th...I told him we will circle back next week. On Jul 2, 2015, at 2:26 PM, jeffrey E. < > wrote: Forwarded message From: Jeffrey Port <1 Date: Thu, Jul 2, 2015 at 7:37 PM Subject: RE: To: "jeffrey E." Jeff Can we do something

From: To: Jeffrey Epstein Subject: Jeff Port Date: Thu, 02 Jul 2015 19:38:

From: To: Jeffrey Epstein Subject: Jeff Port Date: Thu, 02 Jul 201

be fine. look forward to meeting you On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port < wrote: Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie

From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Jeff Port Date: Thu, 02 Jul 2015 19:38:50 +0000 Jeff is tentatively scheduled for 3pm on July 9th...I told him we

2 Jul 2015 19:38:50 +0000 Jeff is tentatively scheduled for 3pm on July 9th...I told him we will circle back next week. On Jul 2, 2015, at 2:26 PM, Jeffrey E. <[email protected]> wrote: Forwarded message From: Jeffrey Port <1 Date: Thu, Jul 2, 2015 at 7:37 PM Subject: RE: To: "jeffrey E." <jeeva

From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Jeff Port Date

From: Lesley Groff To: Jeffrey Epstein <[email protected]> Subject: Jeff Po

e fine. look forward to meeting you On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port < > wrote: Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie

From: Lesley Groff To: Jefffrey Epstein Subject: Fwd: Intro via Dr Jeff Port - Angiocrine Bioscience Update Date: Sun, 07 May 2017 20:10:15 +0000 Attachments: Angiocrine_Bioscienceinvest

l Finnegan • Date: May 7, 2017 at 4:03:08 PM EDT To: " Cc: Jeffrey Port Subject: RE: Intro via Di- Jeff Port - Angiocrine Bioscience Update Dear Jeffrey, Hope this email finds all is well with you and your family. It's been about a year-and-a-half since we met at your residence in Manhattan. Since

via Di- Jeff Port - Angiocrine Bioscience Update Dear Jeffrey, Hope this email finds all is well with you and

From: Lesley Groff To: Jefffrey Epstein Subject: Fwd: Intro via Dr Jeff Port - Angiocrin

pe this email finds all is well with you and your family. It's been about a year-and-a-half since we met at your residence in Manhattan. Since then Angiocrine team and programs have progressed forward. We moved the company to San Diego. We were awarded a $3.8M non-dilutive grant from CIRM, the State of Cal

jeevacation®gmail.com" <jeevacation®gmail.com> Cc: Jeffrey Port < Subject: RE: Angiocrine Bioscience Update Date: Tue, 15 Mar 2016 01:09:07 +0000 Dear Jeffrey, Since our last communication among you, Dr. Jeff Port and me, we have made a series of advances which we are excited to share with you. Just to r

evacation®gmail.com" <jeevacation®gmail.com> Cc: Jeffrey Port < Subject: RE: Angiocrine Bioscience Update

been awarded 4 out of 4 highly competitive grants: (1) CIRM, (2) SBIR-NIH, (3) SBIR-NCI, and (4) NYSTEM—the latter, $15.8M awarded to Cornell while Angiocrine retains full commercial rights. Other highlights: • Signed a 3-year Corporate Agreement with TerumoBCT, a division of Terumo Corporation (publicl

ubject: Fwd: Date: Thu, 02 Jul 2015 18:26:25 +0000 Forwarded message From: Jeffrey Port < Date: Thu, Jul 2, 2015 at 7:37 PM Subject: RE: To: "jeffrey E." Jeff Can we do something early on the 9th JP From: jeffrey E. [mailto: Sent: Thursday, July 02, 2015 10:52 AM To: Jeffrey Port Subject: Re: i wi

From: "Jeffrey E." -4 To: Subject: Fwd: Date: Thu, 02 Jul 201

be fine. look forward to meeting you On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port < wrote: Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie

From: "jeffrey E." <[email protected]> To: Subject: Fwd: Date

015 18:26:25 +0000 Forwarded message From: Jeffrey Port < Date: Thu, Jul 2, 2015 at 7:37 PM Subjec

e fine. look forward to meeting you On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port < > wrote: Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie

From: "Jeffrey E." <[email protected]> To: Jeffrey Port Subject

From: "Jeffrey E." <[email protected]> To: Jeffrey Port Sub

e fine. look forward to meeting you On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port < > wrote: Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie

From: Jeffrey Port To: "'Jeffrey E."' <[email protected]>

From: Jeffrey Port To: "'Jeffrey E."' <[email protected]> Subject: RE: Date: Thu

be fine. look forward to meeting you On Thu, Jul 2, 2015 at 4:41 PM, Jeffrey Port < wrote: Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie

From: jeffrey E. <[email protected]> Sent: Thursday, July 2, 2015 2:52 PM To: Jeffrey Port Subject: Re: i will be back either the 9th or the 14th, either d

com> Sent: Thursday, July 2, 2015 2:52 PM To: Jeffrey Port Subject: Re: i will be back either the 9t

to meeting you </=iv> On Thu, Jul 2= 2015 at 4:41 PM, Jeffrey Port < <mailto » wrote:=br> Jeff Hope all well Wanted=to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a=50 million pre money valuation. We=are offering a 25% discount to the serie

From: Jeffrey Port II=In To: [email protected] Cc: 'PW F'

30 +0000 Attachments: Angiocrine_Bioscience_Confidential_NUMBERS_deck_Jun_2015_v 150701.pptx Jeff Hope all well Wanted to provide the numbers for Angiocrine In summary, we are heading out by summers end for a series B raise at a 50 million pre money valuation. We are offering a 25% discount to the serie